510(k) Report

510(k) · Cleared

Cleared

Hemasorb Absorbable Bone Hemostat Matrix

K111575510(k) TraditionalCleared May 23, 2012352-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orthocon, Inc. · MTJ Wax, Bone

Cleared on May 23, 2012 as substantially equivalent to K043260 (Orthocon, LLC, 2005) and 3 other predicates after a 352-day review. Its family tree reaches back 10 generations to 1979. 6 later devices descend from it.

Decided
May 23, 2012
Review
352 days
Class
Class U
Product code
MTJ
Recalls
None
Predicates
4

Its longest line of descent runs back 10 generations to K791495 (1979). 22 ancestors in all. 6 later devices descend from it, 3 citing it directly.

  1. Root · 10 generations backK791495 Lukens Bone Wax (Gamma Radiation)Lukens Corp. · 1979
  2. 6 generations between
  3. 3 generations backK082491 Ostene CT Soluble Bone Hemostasis Implant Material, Aoc CT, Aoc…Ceremed, Inc. · 2008
  4. 2 generations backK091636 Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc. · 2009
  5. 1 generation backK102071 Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc. · 2010
  6. This deviceK111575 Hemasorb Absorbable Bone Hemostat MatrixOrthocon, Inc. · 2012
  7. Descendant · cites it directly · 3 of its ownK213418 MONTAGE Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc. · 2023
  8. Descendant · 2 generations on · 1 of its ownK242050 Montage Settable Bone PuttyOrthocon, Inc. · 2024
  9. Descendant · 2 generations on · 1 of its ownK232998 Montage- XT Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc. · 2023
  10. Descendant · 3 generations on · 0 of its ownK243506 Montage-XT Settable Bone PuttyOrthocon, Inc. · 2024
  11. Descendant · cites it directly · 0 of its ownK142339 HEMASORB Resorbable Hemostatic Bone PuttyOrthocon, LLC · 2014
Show all 10 generations
  1. Root · 10 generations backK791495 Lukens Bone Wax (Gamma Radiation)Lukens Corp. · 1979
  2. 9 generations backK971680 Auto Suture Bone WaxUnited States Surgical, A Division of Tyco Healthc · 1997
  3. 8 generations backK041363 Aoc Bone WaxCeremed, Inc. · 2004 · Recalled
  4. 7 generations backK050440 Aoc Bone Wax, Ostene, Osteotene, Orthoseal, Osteoseal, Ceretene…Ceremed, Inc. · 2005
  5. 6 generations backK052528 Aoc Bone Wax Ostene, Osteotene and CereteneCeremed, Inc. · 2005
  6. 5 generations backK062280 Ostene, Aoc, Osteotene, Ceretene, Cerepor, Aptene, Apatene and…Ceremed, Inc. · 2006
  7. 4 generations backK070093 Ostene, Aoc, Osteotene, Ceretene, Cerepor, Aptene, Apatene, ActipasteCeremed, Inc. · 2007
  8. 3 generations backK082491 Ostene CT Soluble Bone Hemostasis Implant Material, Aoc CT, Aoc…Ceremed, Inc. · 2008
  9. 2 generations backK091636 Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc. · 2009
  10. 1 generation backK102071 Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc. · 2010
  11. This deviceK111575 Hemasorb Absorbable Bone Hemostat MatrixOrthocon, Inc. · 2012

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2012: 12014: 12023: 22024: 2
2012high 2 (2023) · low 0 (2013)2026

Most influential descendants

Showing 5 of 6 · See all
  • K213418MONTAGE Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc. · 2023 · cites it directly3descendants
  • K242050Montage Settable Bone PuttyOrthocon, Inc. · 2024 · 2 generations on1descendant
  • K232998Montage- XT Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc. · 2023 · 2 generations on1descendant
  • K243506Montage-XT Settable Bone PuttyOrthocon, Inc. · 2024 · 3 generations on0descendants
  • K142339HEMASORB Resorbable Hemostatic Bone PuttyOrthocon, LLC · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K791495Lukens Bone Wax (Gamma Radiation)Lukens Corp.1979—
−9K971680Auto Suture Bone WaxUnited States Surgical, A Division of Tyco Healthc1997—
−8K041363Aoc Bone WaxCeremed, Inc.20041
−7K050440Aoc Bone Wax, Ostene, Osteotene, Orthoseal, Osteoseal, Ceretene, Model BW-12Ceremed, Inc.2005—
−6K052528Aoc Bone Wax Ostene, Osteotene and CereteneCeremed, Inc.2005—
−5K062280Ostene, Aoc, Osteotene, Ceretene, Cerepor, Aptene, Apatene and ActipasteCeremed, Inc.2006—
−4K070093Ostene, Aoc, Osteotene, Ceretene, Cerepor, Aptene, Apatene, ActipasteCeremed, Inc.2007—
−3K082491Ostene CT Soluble Bone Hemostasis Implant Material, Aoc CT, Aoc, Ostene…Ceremed, Inc.2008—
−2K091636Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc.2009—
−1K102071Ostene CT, Aoc CT, Osteotene, CereteneCeremed, Inc.2010—
0 (this device)K111575Hemasorb Absorbable Bone Hemostat MatrixOrthocon, Inc.2012—
+1K213418MONTAGE Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc.2023—
+2K242050Montage Settable Bone PuttyOrthocon, Inc.2024—
+2K232998Montage- XT Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc.2023—
+3K243506Montage-XT Settable Bone PuttyOrthocon, Inc.2024—
+1K142339HEMASORB Resorbable Hemostatic Bone PuttyOrthocon, LLC2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199610
200010
200220
200320
200410
200520
200910
201110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201410
202320
202420
FIG. 1 — Lineage of K111575, 1979–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MTJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MTJ device

  1. #1 K262769 Permatage XT Settable Nonabsorbable Hemostatic…score 15.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K043260Orthocon LLC Orthostat Hemostatic Bone Putty
Summary page 2
…be dispersed and substantially absorbed within a period of 30 days. Predicate Devices: Hemasorb was shown to be substantially equivalent to previously cleared devices (K043260, K091 121, K102762, and K102071). Substantial Equivalence: Hemasorb Resorbable Hemostatic Bone Putty is substantially equivalent…
Orthocon, LLC2005—
*K091121Orthostat
Summary page 2
…rsed and substantially absorbed within a period of 30 days. Predicate Devices: Hemasorb was shown to be substantially equivalent to previously cleared devices (K043260, K091 121, K102762, and K102071). Substantial Equivalence: Hemasorb Resorbable Hemostatic Bone Putty is substantially equivalent to predic…
Orthocon, Inc.2009—
*K102762Orthostat Bone Hemostat Matrix Applicator
Summary page 2
…ubstantially absorbed within a period of 30 days. Predicate Devices: Hemasorb was shown to be substantially equivalent to previously cleared devices (K043260, K091 121, K102762, and K102071). Substantial Equivalence: Hemasorb Resorbable Hemostatic Bone Putty is substantially equivalent to predicate devic…
Orthocon, Inc.2011—
*K102071Ostene CT, Aoc CT, Osteotene, Ceretene
Summary page 2
…absorbed within a period of 30 days. Predicate Devices: Hemasorb was shown to be substantially equivalent to previously cleared devices (K043260, K091 121, K102762, and K102071). Substantial Equivalence: Hemasorb Resorbable Hemostatic Bone Putty is substantially equivalent to predicate devices in indicat…
Ceremed, Inc.2010—

Also cleared against K043260: 6 other devices →

What descends from it? (6)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K213418MONTAGE Settable, Resorbable Hemostatic Bone PuttyOrthocon, Inc.20233
K142339HEMASORB Resorbable Hemostatic Bone PuttyOrthocon, LLC20140
K121953Hemasorb ApplyOrthocon, Inc.20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 4 companies; a new generation was cleared every 1.3 years on median.
  • 4 of the 22 ancestors have a recall of any class.
  • Of its descendants, K213418 (Orthocon, Inc., 2023) has gone furthest, with 3 descendants of its own.
  • 6 other devices also cite its predicate K043260.

How does its category compare?

All MTJ devices

MTJ Wax, Bone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · MTJ

4in 2023

2008: 12009: 22010: 12011: 52012: 32013: 22014: 42015: 22016: 22019: 12020: 12021: 12022: 12023: 42026 (partial year): 2
2007high 5 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MTJ

370in 2023

2011: 140 days median2012: 141 days median2014: 46 days median2023: 370 days median
2007high 370 (2023) · low 46 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MTJ

1in 2023

2008: 12023: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MTJ

22in 2025

2007: 22008: 12011: 22012: 82013: 52014: 62015: 112016: 72017: 72018: 122019: 172020: 162021: 122022: 312023: 202024: 322025: 22
2007high 32 (2024) · low 0 (2009)2025

MAUDE reports naming product code MTJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—11
20092—00
20101—00
2011514002
2012314108
20132—05
201444606
20152—011
20162—07
20170—07
20180—012
20191—017
20201—016
20211—012
20221—031
20234370120
20240—032
20250—022
20262—0—

What is it indicated for?

Hemasorb Resorbable Hemostatic Bone Putty is indicated for use in the control of bleeding from cut or damaged bone by acting as a mechanical barrier or tamponade. The material may be used during surgical procedures and in treating traumatic injuries. Hemasorb Resorbable Hemostatic Bone Putty is also indicated for use in the control of bleeding from bone surfaces in cardiothoracic surgery following sternotomy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K111575: Hemasorb Absorbable Bone Hemostat Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111575

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026